Open Invoices is a metric that measures the total number of invoices that have been issued to customers but have not been marked as paid or voided.
With Databox you can track all your metrics from various data sources in one place.
Used to show a simple Metric or to draw attention to one key number.
Databox is a business analytics software that allows you to track and visualize your most important metrics from any data source in one centralized platform.
To track Open Invoices using Databox, follow these steps:
MRR (excl. Canceled Subscriptions) by Plan Name is a metric that measures the total Monthly Recurring Revenue generated by each subscription plan offered by a business excluding canceled subscriptions. It helps businesses assess the popularity and profitability of different subscription plans, and make data-driven decisions on pricing, promotions and product offering.
Churned MRR by Plan Name is a metric that measures the lost revenue from canceled or downgraded subscriptions, segmented by different plan names. It helps to identify which plans have higher or lower churn rates and take actions to reduce churn.
Churned ARR measures the loss in recurring revenue from existing customers over a year. It helps companies understand their customer retention rate and revenue growth potential.
New Subscriptions (incl. Trials and Inactive Plans) metric tracks the number of new recurring payments or subscription sign-ups including Trials, Active Plans, and Inactive Plans made by customers in a given period of time.
The New Subscriptions metric tracks the number of new recurring payments or subscription sign-ups made by customers in a given period of time.
The Downgrades by Previous Plan Name metric measures the number of times customers have switched to a lower-tier subscription plan from the specific plan they were previously subscribed to.
Discounts is a metric that reflects the total revenue reduction due to discounts applied to monthly recurring revenue (MRR) of a business through Stripe.
Net Active Trials measures the change in the Active Trials over a specific time period.